Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional proteomics: mapping protein-protein interactions and pathways.

Daniel Figeys1

  • 1MDS-Proteomics, Toronto, Ontario, Canada. dfigeys@mdsp.com

Current Opinion in Molecular Therapeutics
|July 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MetaTree: an interactive web platform for aligned hierarchical data visualization and multi-group comparison.

BMC bioinformatics·2026
Same author

Individual variability shapes ex vivo responses to resistant starch in inflammatory bowel disease derived microbiomes.

NPJ biofilms and microbiomes·2026
Same author

MetaDIA: A DDA-free Database Reduction Strategy for DIA Human Gut Metaproteomics.

Genomics, proteomics & bioinformatics·2026
Same author

Microbiome-dependent functional responses to structurally distinct oligosaccharides revealed by metaproteomics.

NPJ biofilms and microbiomes·2025
Same author

Systematic metaproteomics mapping reveals functional and ecological landscapes of Ex vivo human gut microbiota responses to therapeutic drugs.

Nature communications·2025
Same author

Peptide abundance correlations in metaproteomics enhance taxonomic and functional analysis of the human gut microbiome.

NPJ biofilms and microbiomes·2025
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Functional proteomics maps protein interactions to discover new protein functions. This high-throughput approach aids pharmaceutical companies in drug discovery by strengthening genomic efforts.

Area of Science:

  • Proteomics
  • Genomics
  • Drug Discovery

Background:

  • Protein function is determined by interactions with other molecules.
  • Mapping these interactions reveals new protein functionalities.
  • The human genome sequence enables high-throughput interaction mapping.

Purpose of the Study:

  • To review recent advancements in functional proteomics.
  • To highlight the importance of functional proteomics in drug discovery.
  • To discuss the impact of high-throughput interaction mapping.

Main Methods:

  • High-throughput mapping of protein-protein interactions.
  • Utilizing the draft sequence of the human genome.
  • Technological developments in functional proteomics.

Related Experiment Videos

Main Results:

  • Functional proteomics allows for the identification of novel protein functions.
  • It aids in understanding the roles of known proteins.
  • Recent developments enhance the efficiency of interaction mapping.

Conclusions:

  • Functional proteomics is a key technology for pharmaceutical research.
  • It supports genomic efforts and drug discovery pipelines.
  • Continued advancements are crucial for future biological insights.